Skip to main content
OpenTrials
Completed

NCT Number: NCT01495338

A Comparison of the Safety and Comfort of AC-170

The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Normal Ocular Health

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Andover Eye Associates

Andover, Massachusetts, 01810, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able and willing to avoid the use of ocular medications or topical ocular preparations within protocol specific time period.

Exclusion criteria

  • Known contraindications or sensitivities to the study medication or its components.
  • Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters.
  • Use of disallowed medications during the period indicated prior to the study enrollment or during the study.

Treatment and study plan

AC-170 0.17%

Drug

1 drop in one eye at one timepoint

AC-170 0.24% (Formulation 1)

Drug

1 drop in one eye at one timepoint

AC-170 0.24% (Formulation 2)

Drug

1 drop in one eye at one timepoint

Olopatadine hydrochloride 0.2%/Tears Naturale II

Drug

1 drop in one eye at one timepoint

Primary outcomes

  1. Drop Comfort Score

    Time frame: during 3 minute period

    drop comfort on 0-10 scale

Sponsors and collaborators

Lead sponsor

Aciex Therapeutics, Inc.

Industry

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Dec 20, 2011
Registry last updated
Sep 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.